Immunotherapy for Cancer with Designer T-cells and Nk Cells
Scientists have created a novel, hybrid immune cell that combines two kinds of immune cells—T cells and natural killer (NK) cells, which can destroy cancer cells.
Scientists have created a novel, hybrid immune cell that combines two kinds of immune cells—T cells and natural killer (NK) cells, which can destroy cancer cells.
What do we mean when we say: “What do we mean when we say ‘general defense’ and ‘specific defense’ of the body against foreign materials or microorganism that enter it?”
The researchers said they want access to new target antibodies quickly to aid in their research. IMGENEX is pleased to offer researchers access to products that are not fully characterized and validated. IMGENEX antibodies shown by ELISA IMX peptide to bind to the peptide used as immunogen.
Most of the effective medicines we use today were inspired by nature.
Factories that produce antibodies grew bacteria such as E.Coli in a medium or both to form harmless bacteria. The harmless bacteria are then transfer to mammalian cells to produce a large number of antibodies.